NCT06987695: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
- State
- Under way
- Phase
- Phase 3
- People
- 279 taking part
- Started
- 13 Jun 2025
- Primary completion
- 27 Apr 2027
- Arms
- Maridebart Cafraglutide High Dose, Maridebart Cafraglutide Medium Dose, Maridebart Cafraglutide Low Dose
- Results
- None posted
- 23 May 2025: Trial registered
- 13 Jun 2025: Trial started